Lowell J A, Rossi R L, Munson J L, Braasch J W
Department of General Surgery, Lahey Clinic Medical Center, Burlington, Mass 01805.
Arch Surg. 1992 May;127(5):557-60. doi: 10.1001/archsurg.1992.01420050081010.
Duodenal adenocarcinoma, a rare malignant lesion, is associated with a poor 5-year survival. Few series have addressed differences between resectable tumors of the proximal and distal duodenum. We reviewed records of 17 consecutive patients with adenocarcinoma of the duodenum who underwent resection: 10 had adenocarcinoma of the proximal duodenum, and seven had tumors of the distal duodenum. Most patients underwent pancreatoduodenectomy. Five patients with adenocarcinoma of the distal duodenum underwent segmental resection. No perioperative deaths occurred. Six of 10 patients with proximal tumors died of metastatic disease. Of the seven patients with tumors of the distal duodenum, five are alive without evidence of disease, and two died of unrelated causes. The survival of patients with adenocarcinoma of the distal duodenum is surprisingly good, and segmental resection is the procedure of choice.
十二指肠腺癌是一种罕见的恶性病变,其5年生存率较低。很少有系列研究探讨十二指肠近端和远端可切除肿瘤之间的差异。我们回顾了17例连续接受十二指肠腺癌切除术患者的记录:10例为十二指肠近端腺癌,7例为十二指肠远端肿瘤。大多数患者接受了胰十二指肠切除术。5例十二指肠远端腺癌患者接受了节段性切除术。围手术期无死亡病例。10例近端肿瘤患者中有6例死于转移性疾病。7例十二指肠远端肿瘤患者中,5例存活且无疾病证据,2例死于无关原因。十二指肠远端腺癌患者的生存率出奇地好,节段性切除术是首选术式。